# OTARMENI

NDC: 61755-062
Generic name: lunsotogene parvec
Labeler / Manufacturer: Regeneron Pharmaceuticals, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION, SOLUTION
Routes: INTRACOCHLEAR
Marketing started: 20260423

FDA application: BLA125874

## Active ingredients

- LUNSOTOGENE PARVEC 3' VECTOR: 30000000000000 {GC}/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"61755-062"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=61755-062
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a7a5e936-ab4a-4609-ac10-96efedc89035